📋 Tender Overview
Since the beginning of 2019 specialists from the Rosselkhoznadzor Office in the Bryansk and Smolensk regions in both regions have selected 1175 samples of meat products produced by enterprises of the Russian Federation.Samples were taken from products in the trade turnover of the Bryansk and Smolensk regions and directly from manufacturers. Laboratory studies were carried out on the basis of the Bryansk MVL subordinate to the Rosselkhoznadzor.The results showed that in 209 samples there were found inconsistencies with the current requirements of the EAEU technical regulations on the presence of residual content of drugs groups of coccidiostatics quinolones penicillins tetracyclines non-steroidal anti-inflammatory drugs macrolides linkazamides pleuromutilins sulfonamides anti-gel preparations animals as well as BGKP and KMAFAnM Listeria and Salmonella. In addition discrepancies were revealed in the histological composition undeclared components mass fraction of protein moisture fat and starch.In general the percentage of detection was lower than the same indicator last year.In this case inconsistencies were revealed both among manufacturers of the Bryansk and Smolensk regions and among manufacturers from Moscow Belgorod Vladimir Kaluga Kursk Leningrad Moscow Oryol Saratov Tambov regions as well as the Krasnodar Territory.Enterprises that repeatedly allowed the manufacture of products of inadequate quality and safety were brought to administrative responsibility by the Rosselkhoznadzor Administration in the form of fines and the cancellation of the declaration of conformity.In addition the Rosselkhoznadzor Administration using the Mercury state system established raw material zones from which meat raw materials containing unacceptable amounts of drug residues were sent for processing. To take corrective measures an additional laboratory control was organized in the area of responsibility of the Office.Information about products that do not meet the quality and safety requirements developed by enterprises of other entities was sent to manufacturers as well as to authorities in the field of veterinary medicine of the respective regions.
